HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia

Abstract : Dysregulation in calcium (Ca2+) signaling is a hallmark of chronic lymphocytic leukemia (CLL). While the role of the B cell receptor (BCR) Ca2+ pathway has been associated with disease progression, the importance of the newly described constitutive Ca2+ entry (CE) pathway is less clear. In addition, we hypothesized that these differences reflect modifications of the CE pathway and Ca2+ actors such as Orai1, transient receptor potential canonical (TRPC) 1, and stromal interaction molecule 1 (STIM1), the latter being the focus of this study.
Document type :
Journal articles
Complete list of metadata

https://hal.univ-brest.fr/hal-02114358
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Monday, April 29, 2019 - 3:40:45 PM
Last modification on : Monday, March 28, 2022 - 12:10:05 PM

Links full text

Identifiers

Collections

Citation

Marjolaine Debant, Miguel Burgos, Patrice Hémon, Paul Buscaglia, Tinhinane Fali, et al.. STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia. Journal for Immunotherapy of Cancer, BMJ Publishing Group 2019, 7 (1), pp.111. ⟨10.1186/s40425-019-0591-3⟩. ⟨hal-02114358⟩

Share

Metrics

Record views

38